U.S. Luxury Stock News

Williams-Sonoma (WSM) has wrapped up FY 2026 with fourth quarter revenue of US$2.4b and basic EPS of US$3.09, set against a trailing twelve month revenue base of US$7.8b and EPS of US$8.96. Over recent quarters the company has seen revenue move from US$2.5b in Q4 FY 2025 to US$2.4b in Q4 FY 2026, while quarterly EPS shifted from US$3.12 to US$3.09. This is prompting investors to focus on how modest growth expectations line up with a slightly lower trailing net margin and what that may...

SL Green Realty (NYSE:SLG) has agreed to sell the residential and retail components of 7 Dey Street. The company reports that One Madison Avenue is now fully leased. SL Green also highlights significant Manhattan leasing activity so far this year. For investors watching NYSE:SLG, these updates come at a time when the stock trades at $38.37 and has seen very different returns over various time frames, with a 1.5% gain over the past week alongside a 31.8% decline over the past year and a...

Wondering if F5 at around US$282.20 is offering good value or asking too much? This breakdown is designed to help you frame that question clearly before you make any moves. The stock has seen mixed recent returns, with a 2.5% decline over the last 7 days, a 3.0% gain over the past month, 10.0% year to date, and 4.4% over the last year. The 3 year and 5 year returns stand at 100.6% and 42.7% respectively. Recent coverage around F5 has focused on how investors are weighing long term...

Agree Realty Corporation recently declared a monthly cash dividend of US$0.262 per common share and US$0.08854 per Series A preferred depositary share, with the payouts scheduled in April 2026 to shareholders of record in March, marking an annualized increase in the common dividend. This dividend increase, alongside very large growth in institutional holdings and reaffirmed analyst confidence, highlights how income-focused investors view Agree Realty’s retail-focused portfolio as an...

Nordic American Tankers (NYSE:NAT) has agreed to sell a 2005 built vessel for around US$40 million. Management describes the transaction as aligned with the company’s current positioning and plans for future fleet growth. The deal affects fleet composition and adds flexibility around capital allocation going forward. The sale comes as Nordic American Tankers trades at a share price of US$5.42, with the stock up 3.4% over the past week and 19.4% over the past month. Returns of 60.8% year to...

In the past week, Wells Fargo upgraded Dover Corporation to Overweight, citing accelerating organic growth, margin expansion from restructuring efforts, and a supportive U.S. industrial demand backdrop alongside limited Middle East exposure. The upgrade also drew attention to Dover’s Q4 2025 organic growth of 5.0%, 2026 adjusted EPS guidance of US$10.45–US$10.65, and a US$500 million accelerated share repurchase that together emphasize management’s focus on earnings resilience and capital...

Earnings reset and dividend decision put ZIM Integrated Shipping Services (ZIM) in focus ZIM Integrated Shipping Services (ZIM) reported sharply lower quarterly and full year 2025 net income compared with 2024, while its board approved a cash dividend equal to roughly half of annual earnings. The earnings reset, together with a US$106 million fourth quarter dividend and a full year payout of US$1.99 per share, gives investors fresh information to assess the stock’s income profile and recent...

In the recent quarter, Atmus Filtration Technologies, the 2023 Cummins spin-off, reported a 9.8% year-on-year revenue increase and surpassed analyst expectations on both revenue and EBITDA, reflecting strong operational execution across its filtration portfolio. This outperformance suggests that demand for Atmus’ emissions-reducing and engine-protecting filtration solutions is currently running ahead of market assumptions, potentially reshaping how investors assess its earnings profile...

If you are wondering whether Diamondback Energy's current share price still lines up with its underlying worth, the next sections will walk through what the numbers are actually saying about value. The stock last closed at US$189.68, with returns of 7.4% over 7 days, 12.1% over 30 days, 24.5% year to date, 23.6% over 1 year, 65.6% over 3 years, and 215.1% over 5 years. This naturally raises questions about how much of this is already reflected in the valuation. Recent coverage has focused on...

Bank7 (BSVN) FY 2025 earnings snapshot Bank7 (BSVN) has wrapped up FY 2025 with fourth quarter revenue of US$24.1 million and basic EPS of US$1.14, while trailing 12 month revenue came in at US$95.7 million and EPS at US$4.56. Over the past six quarters, revenue has ranged between US$22.6 million and US$24.9 million per quarter as EPS moved between US$1.10 and US$1.26. This gives you a clear line of sight on how the top line and per share profits have tracked into the latest print. With a net...

In March 2026, Microvast Holdings, Inc. reported fourth-quarter 2025 sales of US$96.4 million, full-year sales of US$427.52 million, a sharply lower annual net loss of US$29.22 million, and issued 2026 guidance pointing to continued revenue growth while citing tariff, regulatory, and geopolitical headwinds. On the same day, auditor Deloitte Touche Tohmatsu CPA Ltd issued an unqualified opinion but raised doubt about Microvast’s ability to continue as a going concern, highlighting a tension...

General Mills (GIS) has just posted its Q3 2026 numbers, with revenue at US$4.4b and basic EPS of US$0.57, set against a trailing twelve month EPS of US$4.07 on revenue of US$18.4b. Over recent quarters the company has seen revenue move from US$4.8b in Q2 2026 and US$4.5b in Q1 2026 to the latest US$4.4b print, while basic EPS shifted from US$0.77 and US$2.22 in those periods to US$0.57. This sets up a results season where investors are likely to focus squarely on how margins are holding up...

Insmed (NasdaqGS:INSM) has launched Brinsupri, also known as brensocatib, for non cystic fibrosis bronchiectasis. Brinsupri is the first approved therapy for this condition and has already generated significant initial sales. The successful launch marks a material commercial milestone for Insmed and adds a new revenue stream alongside its existing portfolio. Insmed focuses on treatments for serious and rare respiratory diseases, so the approval and rollout of Brinsupri fit directly into its...

Capital Clean Energy Carriers (CCEC) recently sold 12 container vessels, raised about US$472.2 million in net proceeds, and redirected that capital into gas transportation assets, including newbuilding LNG carriers on long-term charters. See our latest analysis for Capital Clean Energy Carriers. Despite the recent asset sales and LNG charter wins, the share price is around US$20.21 with a 30 day share price return of about an 11% decline. The 1 year total shareholder return of 5.67% and 3...

comScore FY 2025 earnings snapshot comScore (SCOR) just closed out FY 2025 with Q4 revenue of US$93.5 million and basic EPS of US$12.77, alongside full year trailing twelve month figures showing revenue of US$357.5 million and a net loss of US$101.8 million. Over recent quarters the company has seen revenue move in a narrow band between US$85.7 million and US$94.9 million per quarter. At the same time, basic EPS has swung from a loss of US$12.79 to a profit of US$12.77. This leaves investors...

Infleqtion (NYSE:INFQ) has delivered the UK’s first operational 100-qubit quantum computer to the National Quantum Computing Centre. The system is based on Infleqtion’s Sqale platform and is the only operational 100-physical-qubit quantum computing system currently installed in a UK national facility. This deployment gives UK researchers and industry direct access to larger scale neutral atom hardware for benchmarking and application testing. For investors watching quantum hardware,...

Palomar Holdings (NasdaqGS:PLMR) reported strong fourth quarter results, with revenue figures that were materially ahead of earlier analyst expectations. The quarter highlighted performance in the company’s catastrophe insurance focus, an area closely watched by investors given recent weather and loss events. This update reflects current operating momentum for Palomar’s specialty insurance franchise and has not been widely discussed in recent coverage. Palomar focuses on specialty and...

Amneal Pharmaceuticals (AMRX) is back in focus after reporting 2025 results, with revenue of US$3.02b, operating income of US$421m, and lower net leverage of 3.5x, alongside 2026 guidance pointing to adjusted EBITDA and EPS growth. See our latest analysis for Amneal Pharmaceuticals. The recent pullback, including a 16.4% 1 month share price return decline to US$12.39, sits against a much stronger backdrop. The 1 year total shareholder return is 41.9%, and the 3 year total shareholder return...

If you are wondering whether Mercury General at around US$87.85 is still offering value or if most of the opportunity has already played out, this overview helps you frame that question clearly. The stock has pulled back with a 0.8% decline over 7 days and a 6.0% decline over 30 days, following very strong returns of 56.5% over 1 year, 216.2% over 3 years and 71.8% over 5 years. Recent attention around the stock has focused on its longer term share price performance and how that compares...

Event context and recent price performance Veralto (VLTO) has been on investors’ radar after recent share price weakness, with the stock down about 11% over the past 3 months and roughly 9% over the past year. See our latest analysis for Veralto. With the share price at $89.99 and a 90 day share price return of 10.7% and 1 year total shareholder return of 8.9%, recent weakness suggests momentum has been fading as investors reassess growth prospects and risk. If this kind of pullback has you...

In March 2026, Gambling.com Group reported that fourth-quarter 2025 sales rose to US$46.24 million and full-year 2025 sales reached US$165.45 million, but the company swung to a full-year net loss of US$32.93 million after recording a US$14.01 million impairment on intangible assets. Alongside these results, the company completed a share buyback of 3,960,663 shares for US$35.58 million and issued 2026 revenue guidance of US$170 million to US$180 million, highlighting a growing focus on data...

If you are wondering whether Cognizant Technology Solutions at around US$60.29 is a bargain or a value trap, the key is to look closely at what the current price actually implies. The stock has recorded a 3.4% decline over the last 7 days and a 9.4% decline over the last 30 days, contributing to a 25.8% decline year to date and a 23.0% decline over the last year. The 3 year return is 10.4%, and the 5 year return is a 15.2% decline. These moves have put valuation in the spotlight, with...

Protalix BioTherapeutics FY 2025 Earnings Snapshot Protalix BioTherapeutics (PLX) has wrapped up FY 2025 with fourth quarter revenue of US$9.1 million and a basic EPS loss of US$0.07, as investors weigh the latest numbers against the share price of US$2.21. The company has seen quarterly revenue move from US$18.2 million in Q4 2024 to US$10.1 million in Q1 2025, US$15.7 million in Q2 2025, US$17.9 million in Q3 2025 and US$9.1 million in Q4 2025. Basic EPS shifted from US$0.09 in Q4 2024 to...

Yuanbao posted its FY 2025 fourth quarter results with revenue of C¥1.2b and basic EPS of C¥7.49, alongside trailing twelve month EPS of C¥55.72 on revenue of C¥4.4b and net income of C¥2.0b. The company has seen revenue move from C¥888.76m and EPS of C¥11.01 in Q4 2024 to C¥1.2b and C¥7.49 respectively in Q4 2025, set against trailing twelve month earnings growth of 360.7% and an increase in net profit margin from 13.3% to 45.9%. For investors, the latest set of numbers points to a business...